Arthritis and rheumatism
-
Arthritis and rheumatism · Jul 2004
Randomized Controlled Trial Clinical TrialEtanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.
To assess the safety and potential efficacy of etanercept in the treatment of Sjögren's syndrome (SS). ⋯ We found no evidence to suggest that treatment with etanercept at a dosage of 25 mg twice weekly for 12 weeks was clinically efficacious in SS. A larger trial will be necessary to definitively address the efficacy of etanercept in the treatment of SS.